Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 18.4.2023Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))6.4.2023O
 17.4.2023Angelini Pharma Österreich GmbH (ANG-AT-1)40601GLIMBAX (sol ora 1x200 ml (liek.skl.))17.4.2023O
 17.4.2023Zentiva, k.s. (ZNT-1)00858Hydrocortison Léčiva (ung 1x10 g (tuba Al))20.4.2023O
 17.4.2023Zentiva, k.s. (ZNT-1)02828Triamcinolon Léčiva crm (crm der 1x10 g (tuba Al))20.4.2023O
 17.4.2023Zentiva, k.s. (ZNT-1)3041BTorvacard Novum 10 mg (tbl flm 90x10 mg (blis.OPA/Al/PVC/Al))20.4.2023O
 17.4.2023Zentiva, k.s. (ZNT-1)7284CLopridam 8 mg/2,5 mg/5 mg (tbl 30x8 mg/2,5 mg/5 mg (blis.OPA/Al/PVC/Al))20.4.2023O
 17.4.2023Zentiva, k.s. (ZNT-1)84760Rosucard 20 mg filmom obalené tablety (tbl flm 30x20 mg (blis.OPA/Al/PVC//Al))20.4.2023O
 17.4.2023Zentiva, k.s. (ZNT-1)84762Rosucard 20 mg filmom obalené tablety (tbl flm 90x20 mg (blis.OPA/Al/PVC//Al))20.4.2023O
 17.4.2023Hikma Farmaceutica (Portugal) S.A. (HKP-P)15147CEDROX 250 (gru por 1x60 ml)13.4.2023O
 17.4.2023Hikma Farmaceutica (Portugal) S.A. (HKP-P)34702MEGAMOX BID 1 g (tbl flm 14x1 g (fľ.HDPE))13.4.2023O
 17.4.2023G.L. Pharma GmbH (GLH-2)0445DNeuromultivit filmom obalené tablety (tbl flm 50 (blis.Al/Al))17.4.2023O
 17.4.2023Diurnal Europe B.V. (DIU-NL-1)7484CAlkindi 0,5 mg granulát v kapsulách na otváranie (gra cps 50x0,5 mg (fľ.HDPE))17.4.2023U
 17.4.2023Viatris Limited (VIM)95220Onsetrogen 2 mg/ml (sol inj 5x4 ml/8 mg (amp.skl.hnedá))17.4.2023O
 17.4.2023Mylan Ireland Limited (MNY)50500Ciclosporin Mylan 100 mg (cps mol 50x100 mg (blis. Al/Al))17.4.2023O
 17.4.2023Viatris Healthcare Limited (VIM-1)85901Aurorix 300 mg (tbl flm 30x300 mg (blis.PVC/Al))17.4.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)